Moreover, some studies reported that METTL14 represses colorectal cancer (CRC) development via the PI3K/Akt signaling, upregulated by brain-derived neurotrophic factor (BDNF), which revealed similar evidence with our GO results. The gene discussed is BDNF; the disease is colorectal carcinoma.